Carazolol
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Overview
Carazolol is a high affinity antagonist/partial inverse agonist (also referred to as a beta blocker) of the β-adrenergic receptor.[1]
External links
External links
- Carazolol at the US National Library of Medicine Medical Subject Headings (MeSH)
Looking for the patient version?
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH
